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Histone HI is a eukaryotic repressor which recognizes specific DNA structures, and nucleotides regulate its interaction with DNA. Since their mode 
of action may bc considered similar to that obscrvcd in the case of plasma membrane GTPdses, Hl may be regarded as an ATP/GTPase involved 
in the action of nuclear receptors. A hypothesis is put forward here to suggest that transcriptional activators CTF/NF-I and AP-I @sY;un). for 
example, are effecters for HI HI and CTF/NF-I may be members of a stimulatory regulatory cascade for nuclear receptor action that ends with 
selective activation ofchromatin through histone modification and the disruption or a more subtle structural change of a specific nucleosome. while 
an opposite cffcct may be obtained through modification ofjtiJ/jijun by HI. 
Histone HI; Nuclear receptor; CTFiNF-I; AP-I: Nucleosome; GTPase 
1. INTRODUCTION 
DNA in eukaryotes is packed into nucleosomes [t] 
which consist of two turns of DNA twined around pairs 
of histones H2A, H2B, H3 and H4, and histone Hi 
binds to the spacer/hinge region [2], a site between the 
entering and leaving DNA strands. H3 and H4 differ 
from H2A and H2B with respect o their evolutionary 
origin, and H2A and H2B may be envisaged as being 
deposited on them, obviously bending the DNA in a 
similar manner to prokaryotic HU proteins [3]. 
A novel type of DNA-protein interaction has recent- 
ly been characterized for histones [4], in which recogni- 
tion of an exceptionally narrow minor groove of A+T- 
rich DNA regions takes place through SPKK motifs in 
their mobile tails. The SPKK motifs in many of the core 
histones are subject to acetylation [5] and phosphoryla- 
tion [6], and the presence of these modifications cor- 
relates with chromatin activation [5]. Since acetylation 
evidently impairs the chromatin condensation 
properties of the histones [7] although it does not affect 
DNA binding (Oikarinen, J., Mannermaa, R.-M., 
Tarkka, T., Yli-Mgyry, N. and Niemels, O., un- 
published results) or nucleosome positioning [8], it has 
been suggested that the introduction of this reversible 
modification may release the inhibition brought about 
by chromatin condensation [9], allow transcriptional 
initiation complexes access to the start site [lo] and 
render the nucleosomes negotiable by RNA polymerase 
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upon the transcription activation process [I 11. On the 
other hand, phosphorylation of the histones at SPKK 
motifs has been suggested to impair their DNA binding, 
and this modification may thus also be of regulatory 
importance [6] (Nilsson, P., Thornell, A., Oikarinen, J. 
and Grundstriim, T., unpublished results). 
A hypothesis is put forward here to explain how nu- 
clear receptors, and some other transcriptional regula- 
tory proteins, may be involved in the regulation of the 
posttranslational modification reactions of histones, 
and act through producing changes in the chromatin 
structure. 
2. HISTONE Hl AS A NUCLEOTIDE-BINDTNG 
PROTEIN 
The mode of HI interaction with DNA and the nu- 
cleosome is currently under intense investigation. A 
number of SPKK motifs in the charged, basic C-ter- 
minal tail are thought to direct its binding to the A+T- 
rich nucleosome spacer regions [12]. Several pieces of 
evidence suggest preferential binding of Hl to CTF/NF- 
I [13-151 and AP-1 sites on DNA (Mannermaa, R.-M., 
Yli- MByry, N., Tarkka, T. and Oikarinen, J., un- 
published results), modulation of the function of these 
regulatory proteins thus being an intriguing target for 
the HI action. 
It is evident in the light of recent data that Hl con- 
tains a phosphate and nucleotide binding site [16], 
which interacts preferentially with GDP/GTP and 
ADP/ATP [17,! 81, so that these nucleotides affect Hl 
DNA binding [19]. Nucleoside diphosphates are 
thought to stabilize a state in which Hl binds better to 
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DNA, while nucleoside triphosphatcs impair its binding 
[ 181. H 1 is also able to hydrolyze nucleosidc triphospha- 
tes to nucleoside diphosphates, and incorporate phos- 
phate to exogenous proteins [17]. These findings are of 
utmost interest when extrapolated to the current know- 
ledge on the mechanisms of the regulation of transcrip- 
tion. 
Consistent with the above results, the Hl molecular 
structure displays considerable similarity to that of 
GTPases [18], presence of the loops involved in the 
recognition of guaninc and the hydrolysis of the GTP 
P-r phosphate bond by rcrs-p21 being demonstrable 
(Yli-M2yry, N., Tarkka, T. and Oikarinen, J., unpub- 
lished results). In the light of the above findings, Hl 
may be considered the nuclear ATP/GTPase involved 
in mediating the action of nuclear receptors [20] (Fig. 1). 
3. CTF/NF-1 COUNTERACTS CHROMATIN 
FORMATION 
CTF/NF-I is a eukaryotic DNA-binding protein 
which is involved in both DNA replication and gene 
transcription [21], recognizing preferentially the 5’- 
TTGGCAnnnTGCCAA-3’ sequence with the perfect 
dyad of symmetry [14]. The motifs recognized by H 1 
and CTF/NF-I may be similar in appearance [14], al- 
though the exact consensus sequence for Hl binding 
sites remains unelucidated, and the two proteins may be 
parts of a regulatory system with a common or overlap- 
ping specificity for certain sites on DNA. Several forms 
of CTF/NF-I are synthesized in cells, due to differential 
splicing of primary transcripts arising from a single gene 
or multiple genes displaying heterogeneity in their C- 
terminal parts and in a region within their N-terminal 
DNA-binding domains [22,23]. 
The exact mechanism of CTF/NF-I action is not 
known, although this protein is evidently capable of 
counteracting the packing of DNA into chromatin [24]. 
A number of functionally important regions have been 
identified in CTF/NF-I, comprising the N-terminal 
DNA-binding domain which is per se responsible for 
the activation of DNA replication and a C-terminal 
Pro-rich transcription activation domain [25]. Interest- 
ingly, the CTF/NF-I primary structure displays mar- 
ginal homology with protein kinases and bacterial chlo- 
ramphenicol acetyltransferases (see [26]), and the 
predicted molecular structure has rcveated considerable 
conservation of the regions that had been shown to be 
responsible for the catalytic activity of the acetylases. 
sion [28]. Various forms offos/jun contain a highly ho- 
mologous DNA binding domain and they recognize a 
common consensus DNA sequence, 5’-TGA(C/ 
G)TCA-3’. AP-1 belongs to a larger family of transcrip- 
tional activator proteins characterized by a coiled-coil 
leucine zipper dimerization domain and a basic DNA- 
binding domain in the N-terminal end of the coiled-coil 
~291. 
AP-1 takes part in the regulation of the expression of 
a number of cell proliferation-associated genes such as 
those for various extracetlular proteinases [28,30]. In- 
creased production of various coltagenases, this being 
a group of the proteinases, is required for malignant 
growth and metastasis in neoplastic diseases, and fos 
and jun are per se capable of inducing their synthesis 
and transforming the cells when produced in excess. 
The aberrant expression of the collagenase genes in 
transformed cells, as well as the induction during the 
normal cell division, is blocked by an administration of 
appropriate steroid hormones. The mechanism of the 
inhibition has remained unrevealed to date. Since sever- 
al mechanisms have been demonstrated to be responsi- 
ble for the regulation of AP-1 activity, including modu- 
lation of the synthesis of fos or&n, phosphorylation of 
the proteins and binding of specific inhibitors, the mech- 
anism of the steroid interference with the AP-1 action 
may turn out to be complex [31,32]. 
5. MODE OF ACTION OF NUCLEAR RECEP- 
TORS 
In general, nuclear receptors exert their effects 
through binding to DNA [33]. A ligand such as steroid 
hormone, T,, retinoic acid or 1,25-dihydroxycholecal- 
ciferol is needed for this interaction. The ligand enables 
dissociation of the receptor from depository hsp90 [34] 
and dimerization [35]. Nuclear receptors evidently inter- 
act in addition to hsp90 with other heat shock proteins 
such as hsp70. The significance of these interactions 
remains unelucidated although they may be envisaged 
as taking part in nucleotide exchange, as discussed 
below. Upon binding to DNA, nuclear receptors are 
thought to bring about a change in the chromatin struc- 
ture that results in induction or repression of certain 
genes [36-381. The mechanisms by which the induction 
is brought about are unknown, although they may in- 
volve disruption or a more subtle structural change in 
a specifically positioned nucleosome in the promoter 
region of the inducible gene (Fig. 2) [36,38]. These chan- 
ges may be accompanied by changes in histone acetyla- 
tion [39]. 
It has recently been suggested that nuclear receptors 
may act through mechanisms imilar to those of the 
GTPase-coupled receptors on the plasma membrane 
(for details see e.g. [40]). Considerable homology and 
conservation of the regions responsible for the interac- 
tion of the plasma membrane receptors with GTPases 
4. AP-1 @sljun) AS A TRANSCRIPTIONAL ACTI- 
VATOR 
AP-1, the heterodimeric omplex of various forms of 
fos and jun [27], is a transcription activation protein 
involved in mediating the effects of a number of effec- 
tors such as phorbol esters and TGF-p on gene expres- 
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was observed in the nuclear receptors, thus suggesting 
analogous mechanisms of action and a common evolu- 
tionary origin for the two receptor families [20]. 
6. REGULATORY ROLE OF HISTONE HI 
Hl is thought to act as a eukaryotic repressor [41]. It 
triggers nucleosome aggregation to solenoid structures, 
characteristic of the repressed heterochromatin, with six 
nucleosomes per turn and HI inside the ordered struc- 
ture. On the other hand, a number of experiments ug- 
gest that Hl is more loosely bound to chromatin in 
active areas than in the areas not as efficiently ex- 
pressed, although it is generally thought to be still pre- 
sent [42,43]. It is of interest o speculate how all the 
above findings concerning the regulation of the euka- 
ryotic gene expression by nuclear receptors, CTF/NF-I 
and AP-1 may be put together. 
The presence of an intact CTF/NF-I binding site is 
an absolute requirement for the steroid action in the 
case of MMTV-LTR [36-,381, and this site resides in the 
nucleosome hinge/spacer region, corresponding to the 
site to which H 1 binds in the chromatosome [44]. There 
is increasing evidence that this may also be the case with 
other nuclear receptor-inducible genes. Since the bind- 
ing of steroid receptors to corresponding responsive 
elements results in a change in the structure of this 
nucleosome in particular (Fig. 2) [38], it may be as- 
sumed, by analogy to the mode of action of the recep- 
tors on the plasma membrane (see [40]) that nuclear 
receptors cause dissociation of Hl, the ATP/GTPase, 
from the nucleosome. Consistent with this, differential 
DNA binding of Hl has recently been demonstrated 
upon GDP/GTP exchange [45], this being in agreement 
with the suggestion that nuclear receptors may act by 
enabling the nucleotide exchange in Hl and thereby 
impairing the HI affinity to DNA [19]. 
It has very recently been demonstrated in a number 
of studies that nuclear receptors counteract he effect of 
AP-1 on transcription and vice versa [46-48]. It is evi- 
dent from these experiments hat the effects are not due 
to binding of the two protein families to the same DNA 
element or to overlapping sequences, and the counterac- 
tion of the AP-1 action by steroid receptors actually 
does not necessarily require the binding of the steroid 
receptor to DNA. The effects may be brought about by 
mutual interaction of the two proteins or by that 
through a third protein factor [48]. 
The inhibition of AP-1 action by nuclear receptors 
may involve phosphorylation ofjun at Ser in an SPKK 
motif homologue located towards the amino terminus 
from the coiled-coil dimerization/DNA-binding domain 
and thought to enhance DNA binding of fodjun in a 
cooperative manner [32]. This site ofjun becomes de- 
phosphorylated upon activation of the protein kinase-C 
pathway. The introduction of phosphate to the SPKK 
motif blocks DNA binding of AP-1 [49] and Hl [6], and 
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Fig. I. Schematic representation of hislonc H I as an ATP/GTPase. A 
hypothesis is presented here to suggesl that histone HI is a nucleotide 
binding protein [18], and that GDPiGTP exchange in HI is facilitated 
by nuclear receptors (s&u/ inl~ur) (451. Upon binding of GTP HI is 
incapable of binding to DNA [I$)], and it may interact with effector 
proteins (si,qwl ourpur). Hl itself, or in the presence of auxiliary 
proleins, is capable of hydrolyzing nucleoside triphosphates to corre- 
sponding diphosphates [17]. HI binds to DNA in the presence of the 
nucleoside diphosphate [18]. Acidic activator proteins may facilitate 
the hydrolysis or nucleotide xchange and produce thereby chromatin 
activation [45]. 
introduction of this modification may thus cause the 
inhibition of AP-1 activity upon the steroid treatment. 
It is of interest in this context that Hl , the mediator of 
the nuclear receptor action, is capable of hydrolyzing 
nucleoside triphosphates and phosphorylating exoge- 
nous proteins. The SPKK motif may, at least in some 
situations, be a target for this modification. 
7. ARE CTFINF-I AND fosijun EFFECTORS FOR 
HISTONE H l? 
In conclusion, several pieces of evidence exist that 
nuclear receptors bring about changes in the chromatin 
structure, these changes possibly being responsible for 
the alterations in the DNA template activity. The recent 
findings imply that Hl may be involved in triggering the 
changes, and the effector proteins involved in the puta- 
tive ATP/GTPase action of Hl need to be elucidated. 
When the mode of HI-DNA interaction is taken into 
consideration, HI is expected to bind to the opposite 
side of the DNA double helix when compared with 
CTF/NF-I and fodjun which mainly interact with the 
DNA major groove. This should allow concomitant 
binding of Hl and one of the latter two, to close contact, 
and enable mutual interference with the functioning of 
each other. 
It is even more intriguing to postulate that, upon the 
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r:ig. 2. Steroid receptor-induced di~ruptiorliinodilicatioll of a specilic 
nuclcosomc during chromatin activation. Nuclear receptors such as 
those for steroid hormone:, (SR) bind to I>NA. and exert thcil- cffccts 
through a spccilicall) positioned nuclcosomc (regulatory nucleo- 
sornc). The bindlng ofthc rcccptor to a responsive clement may result 
in a disxxiation or more likely !n a structural change in the rcgdatory 
ndcosornc. and is aasumcd to countwact chromatin condenwtion 
brought about by nucleosomes and histonc HI. c‘T/%V~-/ may bc 
necdcd in the process. Subsequent rcvclation of the transcriptional 
start site allows binding of auxiliary transcription factors to the pro- 
moter (TI;IID). 
nuclear receptor facilitated nucleotide exchange (Fig. 
I), H 1 activates CTFINF-I, a histonc acetylase directed 
to specific sites on DNA (see [26]), since this process 
would result in selective acetylation of the nucleosome 
core histones, interference with their chromatin conden- 
sing capacity and the revelation of a transcriptional 
start site (Fig. 2). Furthermore, there is increasing evi- 
dence that nuclear receptors may be immediate media- 
tors of the growth factor action, changes in the receptor 
activity possibly affecting H 1 function and the chroma- 
tin structure. In agreement with this, a CTFLNF-I bind- 
ing site mediates the stimulatory effect of TGF-P on the 
mouse q(I) collagen gene expression, Hl interacts with 
this site, and the gene is positively regulated at the level 
of transcription by steroid hormones. 
On the other hand, in the case of inhibition of tran- 
scription, phosphorylation of the SPKK motif of,fis/@ 
may take place, and should lead to impaired DNA bind- 
ing and interference with the transcriptional activation 
brought about by that protein. This may ultimately lead 
to a transcriptional block through induction of the re- 
pressed chromatin state, as suggested previously. Con- 
sistent with this, an AP-1 site mediates the inhibitory 
effect of TGF-P on the transin gene expression, HI 
binds to this site (Mannermaa, R.-M., Yli-MByry, N., 
Tarkka, T. and Oikarinen, J., unpublished results) and 
the gene is negatively regulated at the level of transcrip- 
tion by steroid hormones. The two mechanisms put 
forward above would thus, at least partly, explain the 
inhibitory and stimulatory effects of a number of ex- 
tracellular effecters on gene expression, and those 
brought about by the binding of nuclear receptors to 
their responsive DNA elements. 
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